DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 4, 2014--
Covidien
plc (NYSE: COV) will present at the 2014 Leerink Global Healthcare
Conference in New York on Feb. 12. Coleman N. Lannum, vice president,
Investor Relations, will discuss the company in a presentation scheduled
to begin at 11:05 a.m. ET.
A live audio webcast of the presentation can be accessed at Covidien’s
Investor Relations website: http://investor.covidien.com.
An archived edition of the presentation will be available following the
live webcast.
About Covidien
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien develops,
manufactures and sells a diverse range of industry-leading medical
device and supply products. With 2013 revenue of $10.2 billion, Covidien
has more than 38,000 employees worldwide in more than 70 countries, and
its products are sold in over 150 countries. Please visit www.covidien.com
to learn more about our business.
Source: Covidien
Covidien
External Communications
Peter Lucht, 508-452-4168
Vice
President
peter.lucht@covidien.com
or
Investor
Relations
Coleman Lannum, 508-452-4343
CFA, Vice President
cole.lannum@covidien.com
or
Corporate
Communications
Lisa Clemence, 508-452-4375
Director
lisa.clemence@covidien.com
or
Investor
Relations
Todd Carpenter, 508-452-4363
Senior Director
todd.carpenter@covidien.com
| 